Cell and Gene Therapy Supply Chain/Logistics Market Resaerch Report 2024
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Cell and Gene Therapy Supply Chain/Logistics Market Size, Share & Trends Analysis Report By Application area (Donor eligibility assessment, Sample collection, Manufacturing, Logistics, Patient verification, and treatment follow-up), By Type of software solution (Cell orchestration platform, Enterprise manufacturing system, Inventory management system, Laboratory information management system, Logistics management system, Patient management system, Quality management system, Tracking and tracing system ), By Mode of Deployment (Cloud-Based, On-premises ), By End-user (Biobank, Cell therapy lab, Hospital, Research institute, Commercial organization)- Market Outlook And Industry Analysis 2031"
The Global Cell and Gene Therapy Supply Chain/Logistics Market is valued at US$ 1.35 Bn in 2023, and it is expected to reach US$ 3.17 Bn by 2031, with a CAGR of 11.41% during the forecast period of 2024-2031.
Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/1694
?
The cell and gene therapy supply chain/logistics is a system designed to effectively deliver these life-saving treatments to patients. It involves several steps, with special considerations to ensure the fragile therapies are kept safe and viable throughout the journey. Rare diseases are treated with gene and cell treatments. Clinical trials for rare diseases will inevitably take place across many states or perhaps continents. This creates a difficulty that necessitates a robust and interconnected supply chain network, with supply chain participants working together to ensure the safe handling and transportation of temperature-sensitive cargo. The development of cell and gene therapy requires cooperation with logistics suppliers that have many logistical hubs in strategic locations in order to meet service expectations and lower cold chain risk.
?
Training for cell and gene therapy logistics should encompass shipping, storage, preparation, and administration of the therapies. It should also address the patient journey, coordination of treatment, cohort management, manufacturing slots, and involvement of surgical or interventional radiology. Supply chain vendors in cell and gene therapy, such as couriers, depot networks, tracking platforms, and patient concierges, need to be integrated into the logistics oversight.
?
List of Prominent Players in the Cell and Gene Therapy Supply Chain/Logistics Market:
·?????? Be The Match BioTherapies
·?????? MAK-SYSTEM
·?????? Cryoport Systems
·?????? Brooks Life Sciences
·?????? Lykan Bioscience - Now RoslinCT
·?????? Clarkston Consulting
·?????? SAP
·?????? Hypertrust
·?????? Haemonetics
·?????? MasterControl
·?????? TraceLink
·?????? Savsu Technologies
·?????? TrakCel
·?????? Title21 Health Solutions
·?????? sedApta Group
·?????? Vineti
·?????? Stafa Cellular Therapy
·?????? 赛默飞世尔科技 (Patheon)
·?????? McKesson
·?????? Biocair
·?????? Marken (UPS Company)
·?????? Modality Solutions
·?????? Almac Group
·?????? Catalent Pharma Solutions
·?????? BioLife Solutions, Inc.
·?????? Biostór Ireland
·?????? Atelerix Ltd.
·?????? Other Prominent Players
?
Market Dynamics:
Drivers-
Rising adoption of personalized therapies tailored to individual patient needs, particularly for rare and complex diseases. Growth in patient-centric approaches requiring sophisticated logistics solutions. Innovations in gene editing technologies such as CRISPR, enhance the development and delivery of cell and gene therapies. Accelerated approvals and supportive regulatory frameworks from agencies like the FDA and EMA, encourage the development and commercialization of cell and gene therapies. Increased focus on compliance and quality assurance driving the need for specialized logistics. Increased patient awareness and advocacy for access to advanced therapies driving demand and logistical needs.
Challenges:
Ensuring consistent temperature control (cold chain logistics) to maintain the viability and efficacy of therapies during transport and storage. Preventing contamination and preserving the genetic stability of the therapies throughout the supply chain.
Regional Trends:
The North America dominates the market. Leading in the adoption of advanced technologies such as AI, IoT, and blockchain for supply chain optimization and tracking. Significant investments in R&D and infrastructure for cell and gene therapy manufacturing and logistics. Strong regulatory frameworks and support from agencies like the FDA are driving innovation and adoption of cell and gene therapies. The Asia Pacific is rapidly expanding the market for cell and gene therapies, particularly in countries like China, Japan, and South Korea. Increasing government support and investment in biotechnology and regenerative medicine.
?
Curious about this latest version of the report? @ https://www.insightaceanalytic.com/report/cell-and-gene-therapy-supply-chain-logistics-market/1694
Recent Developments:
·?????? In June 2024 Cryoport, Inc., declared a strategic alliance to offer biotechnology and pharmaceutical firms fully integrated manufacturing and logistics services for regenerative medicine products to help the development of cell and gene therapies.
·?????? In November 2023, BioLife Solutions, The company intends to use the USD 10.4 million it raised through a private placement to expand its supply chain services for gene and cell therapies.
·?????? In Oct. 2023, Be The Match BioTherapies?, declared a fresh strategic alliance. IntegriCellTM, a standardized bioprocessing, cryopreservation, and distribution solution for the worldwide cell therapy market, will become even more capable as a result of the partnership.? IntegriCellTM is prepared to support both centralized and decentralized manufacturing methods, facilitating and expediting patient access to cutting-edge novel medicines. Cryopreservation facilities are located in the EU and the US.
Segmentation of Cell and Gene Therapy Supply Chain/Logistics Market-
Application Area
·?????? Donor eligibility assessment
·?????? Sample collection
·?????? Manufacturing
·?????? Logistics
·?????? Patient verification and treatment follow-up
Type of Software Solution
·?????? Cell orchestration platform
·?????? Enterprise manufacturing system
·?????? Inventory management system
领英推荐
·?????? Laboratory information management system
·?????? Logistics management system
·?????? Patient management system
·?????? Quality management system
·?????? Tracking and tracing system
?
End-Use
·?????? Biobank
·?????? Cell Therapy Lab
·?????? Hospital
·?????? Research Institute
·?????? Commercial Organization
Type of Deployment
·?????? Cloud-Based
·?????? On-premises
By Region-
North America-
·?????? The US
·?????? Canada
·?????? Mexico
Europe-
·?????? Germany
·?????? The UK
·?????? France
·?????? Italy
·?????? Spain
·?????? Rest of Europe
Asia-Pacific-
·?????? China
·?????? Japan
·?????? India
·?????? South Korea
·?????? South East Asia
·?????? Rest of Asia Pacific
Latin America-
·?????? Brazil
·?????? Argentina
·?????? Rest of Latin America
?Middle East & Africa-
·?????? GCC Countries
·?????? South Africa
·?????? Rest of the Middle East and Africa
For More Customization @ https://www.insightaceanalytic.com/customisation/1694
Why should buy this report:
?? To receive a comprehensive analysis of the prospects for global Cell and Gene Therapy Supply Chain/Logistics market
?? To receive industry overview and future trends of global Cell and Gene Therapy Supply Chain/Logistics market
?? To analyze the Cell and Gene Therapy Supply Chain/Logistics market drivers and challenges
?? To get information on the Cell and Gene Therapy Supply Chain/Logistics market size value (US$ Mn) forecast till 2031
?? Major Investments, Mergers & Acquisition in global Cell and Gene Therapy Supply Chain/Logistics industry
?
Other Related Reports Published by InsightAce Analytic:
?
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
?
Contact US:
InsightAce Analytic Pvt. Ltd.
Tel.: +1 718 593 4405
Email: [email protected]
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ